Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 4 1Phase 2 1

Status

Completed 4Terminated 2

Sponsor Class

INDUSTRY 3NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Tumor-Agnostic 2Thoracic 2

Conditions

Pancreatic Neoplasms 70Breast Neoplasms 64Neoplasms 35Carcinoma, Non-Small-Cell Lung 29Neoplasm Metastasis 21Triple Negative Breast Neoplasms 18Lung Neoplasms 13Adenocarcinoma 13Ovarian Neoplasms 12Stomach Neoplasms 10Squamous Cell Carcinoma of Head and Neck 10Melanoma 10Head and Neck Neoplasms 8Fallopian Tube Neoplasms 7Cholangiocarcinoma 7Urinary Bladder Neoplasms 6Recurrence 6Esophageal Neoplasms 6Parkinson Disease 4, Autosomal Dominant Lewy Body 5Digestive System Neoplasms 5Colorectal Neoplasms 5Carcinoma, Ovarian Epithelial 5Uterine Cervical Neoplasms 4Sarcoma, Ewing 4Sarcoma 4Prostatic Neoplasms 4Pancreatic Diseases 4Inflammatory Breast Neoplasms 4Gallbladder Neoplasms 4Endocrine Gland Neoplasms 4

Interventions

Carboplatin 27Paclitaxel 24Cisplatin 22Gemcitabine 17pembrolizumab 15Fluorouracil 9Docetaxel 9Pemetrexed 8Everolimus 8Cetuximab 8Radiotherapy, Intensity-Modulated 7Radiotherapy 7Nivolumab 7130-nm albumin-bound paclitaxel 7Sorafenib 6Bevacizumab 6Axitinib 6epothilone B 5Sunitinib 5Radiation 5Panitumumab 5Irinotecan 5Cyclophosphamide 5trebananib 4reolysin 4padeliporfin 4lenvatinib 4Gefitinib 4Albumin-Bound Paclitaxel 4vosaroxin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Carcinoma × Albumin-Bound Paclitaxel × Clear all
NCT04879368 2026-06-10

INTEGRATEIIb

Australasian Gastro-Intestinal Trials Group

Phase 3 Completed
462 enrolled 15 charts
Tumor-Agnostic

Adenocarcinoma, Carcinoma, Neoplasm Metastasis

NCT03976362 2026-02-25

KEYLYNK-008

Merck Sharp & Dohme LLC

Phase 3 Completed
851 enrolled 25 charts
Tumor-Agnostic

Carcinoma

NCT02392507 2020-11-19

A Study of Nab-Paclitaxel and Carboplatin Plus Necitumumab (LY3012211) in Participants With Stage IV Squamous NSCLC

Eli Lilly and Company

Phase 2 Completed
54 enrolled 16 charts
Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung

NCT02151149 2018-09-24

ABOUND 70+

Celgene

Phase 4 Completed
143 enrolled 25 charts
Thoracic

Adenocarcinoma, Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Lung Neoplasms, Carcinoma, Large Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡